Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 5 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 3 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 5 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 5 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 2 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 3 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First...
Morningstar· 7 days agoAlvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S. ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 7 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number of other analysts ...
PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit
Bloomberg Law· 7 days agoA health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting program before a federal appeals ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 6 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie traded as low as $158.56 and last ...
